TORONTO, May 24, 2017 -- Maricann Group Inc. (CSE:MARI) ("Maricann" or the "Company"), a low cost, greenhouse producer of medical cannabis with market leading technological differentiation, is laying down the foundations today for more growth as it breaks ground for its expanding cultivation and production facility in Langton, Ontario.
|
||||||||||
Photos accompanying this announcement are available at:
http://www.globenewswire.com/NewsRoom/AttachmentNg/59594880-514d-469e-9735-5b137c4e04cc
http://www.globenewswire.com/NewsRoom/AttachmentNg/3a72d2e5-611a-4523-a0cc-abf24ba9e989
“Having recently listed publicly, we are now setting the stage for our ongoing physical expansion by way of a major enlargement of our Langton growing facility,” said Ben Ward, CEO of Maricann. “We’re very proud to formally break ground of the first 217,000 sq. ft. of an overall 817,000 sq. ft. greenhouse facility expansion. This expanding facility will give us the scale we need to become one of the world’s leading vertically integrated cannabis companies.”
Maricann originally acquired an 8,000 square foot growing operation in Langton in 2013. Since that time, Maricann has expanded its facility to 44,000 square feet, in which the company currently cultivates, processes and distributes medical cannabis. The new phase of additional construction underway will significantly increase the existing facility’s size.
When Phase 1 is complete in the fall of 2017:
- The expanded Langton facility will be approximately 217,000 square feet, an increase of approximately 833% to the existing domestic facility.
- This expansion increase will drive $80 million in additional annual revenues
- Yield and production will increase 500%, with production of more than 20,000 kilograms by the end of the first year of the expanded facility.
Phase 2, which will start in fourth quarter of 2017, will add an additional 300,000 square feet, an increase of 110% to the same facility, driving even more scale efficiencies.
“Our local team of experts from the food, pharmaceutical and construction sectors help us grow high-quality cannabis plants in Norfolk County, a region widely recognized as Ontario’s garden,” said Jeff Ayotte, Senior Director of Project Management Office. “Our highly energy-efficient growing facility will be operated with low-cost energy supply from both natural gas cogeneration and our active natural gas well on-site. It will be world class once it’s done, building on our deep roots both in the area and in the industry.”
Maricann Milestones
- April 2013, Maricann Inc. is founded in Langton, Ontario, a well-established agricultural region in southwestern Ontario
- March 2014, earned Health Canada licence to cultivate plants
- December 2014, earned Health Canada licence to sell dried cannabis
- January 2015, first dried cannabis sale
- September 2016, earned Health Canada licence to sell cannabis extracts
- October 2016, first sale of extracted cannabis
- December 2016, raised $22 million in capital
- January 2017, commenced sale of clones
- February 2017, raised $10 million in capital
- April 24, 2017, first day of trading
- April 28, 2017, announces Advisory Board of German subsidiary
- May 24, groundbreaking of expanding Langton facility
About Maricann
Maricann is a vertically integrated producer and distributor of marijuana for medical purposes. The company was founded in 2013 and is based in Langton, Ontario, where it operates a cultivation, marijuana extraction and distribution business under federal licence from the Government of Canada. Maricann, which has federal licences to cultivate, process and distribute cannabis, services a patient base with more than 3,000 active patients.
www.maricann.ca
Contact information Shawn Alexander VP Investor Relations [email protected] 416.258.4784 Corporate Headquarters: Maricann Group Inc. (C.MARI) 845 Harrington Court, Unit 3 Burlington Ontario L7N 3P3 Canada Dial Toll Free in North America: 1.844.Maricann (627.4226) International Only: 001.416.916.7145


NVIDIA, Microsoft, and Amazon Eye Massive OpenAI Investment Amid $100B Funding Push
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations
Tesla Q4 Earnings Beat Expectations as Company Accelerates Shift Toward AI and Robotics
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment
Apple Forecasts Strong Revenue Growth as iPhone Demand Surges in China and India
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use
Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex
American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case
Elon Musk’s SpaceX Explores Merger Options With Tesla or xAI, Reports Say
Microsoft AI Spending Surge Sparks Investor Jitters Despite Solid Azure Growth
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million 



